124 related articles for article (PubMed ID: 28221388)
1. Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonists.
Guillaume J; Seki T; Decruy T; Venken K; Elewaut D; Tsuji M; Van Calenbergh S
Org Biomol Chem; 2017 Mar; 15(10):2217-2225. PubMed ID: 28221388
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
[TBL] [Abstract][Full Text] [Related]
3. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
[TBL] [Abstract][Full Text] [Related]
6. 4,5-cis unsaturated α-GalCer analogues distinctly lead to CD1d-mediated Th1-biased NKT cell responses.
Cui Y; Li Z; Cheng Z; Xia C; Zhang Y
Chem Res Toxicol; 2015 Jun; 28(6):1209-15. PubMed ID: 25955524
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands.
Pauwels N; Aspeslagh S; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2012 Dec; 20(24):7149-54. PubMed ID: 23122935
[TBL] [Abstract][Full Text] [Related]
8. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
9. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
[TBL] [Abstract][Full Text] [Related]
10. 4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies.
Janssens J; Bitra A; Wang J; Decruy T; Venken K; van der Eycken J; Elewaut D; Zajonc DM; van Calenbergh S
ChemMedChem; 2019 Jan; 14(1):147-168. PubMed ID: 30556652
[TBL] [Abstract][Full Text] [Related]
11. Efficient synthesis of galactosylceramide analogues for iNKT cell stimulation.
Chen W; Xia C; Cai L; Wang PG
Bioorg Med Chem Lett; 2010 Jul; 20(13):3859-62. PubMed ID: 20627566
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
[TBL] [Abstract][Full Text] [Related]
13. Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.
Chennamadhavuni D; Saavedra-Avila NA; Carreño LJ; Guberman-Pfeffer MJ; Arora P; Yongqing T; Pryce R; Koay HF; Godfrey DI; Keshipeddy S; Richardson SK; Sundararaj S; Lo JH; Wen X; Gascón JA; Yuan W; Rossjohn J; Le Nours J; Porcelli SA; Howell AR
Cell Chem Biol; 2018 May; 25(5):571-584.e8. PubMed ID: 29576533
[TBL] [Abstract][Full Text] [Related]
14. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Dideoxy-3,3,4,4-tetrafluoro- and 4-OH epimeric 3-deoxy-3,3-difluoro-α-GalCer analogues: Synthesis and biological evaluation on human iNKT cells stimulation.
Golten S; Patinec A; Akoumany K; Rocher J; Graton J; Jacquemin D; Le Questel JY; Tessier A; Lebreton J; Blot V; Pipelier M; Douillard JY; Le Pendu J; Linclau B; Dubreuil D
Eur J Med Chem; 2019 Sep; 178():195-213. PubMed ID: 31185411
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of alpha-galactosyl ceramide (KRN7000) and analogues thereof via a common precursor and their preliminary biological assessment.
Michieletti M; Bracci A; Compostella F; De Libero G; Mori L; Fallarini S; Lombardi G; Panza L
J Org Chem; 2008 Nov; 73(22):9192-5. PubMed ID: 18956839
[TBL] [Abstract][Full Text] [Related]
17. Aminocyclitol-substituted phytoceramides and their effects on iNKT cell stimulation.
Harrak Y; Barra CM; Bedia C; Delgado A; Castaño AR; Llebaria A
ChemMedChem; 2009 Oct; 4(10):1608-13. PubMed ID: 19739197
[No Abstract] [Full Text] [Related]
18. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
[TBL] [Abstract][Full Text] [Related]
19. Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
Lacône V; Hunault J; Pipelier M; Blot V; Lecourt T; Rocher J; Turcot-Dubois AL; Marionneau S; Douillard JY; Clément M; Le Pendu J; Bonneville M; Micouin L; Dubreuil D
J Med Chem; 2009 Aug; 52(15):4960-3. PubMed ID: 19580320
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000).
Shiozaki M; Tashiro T; Koshino H; Nakagawa R; Inoue S; Shigeura T; Watarai H; Taniguchi M; Mori K
Carbohydr Res; 2010 Aug; 345(12):1663-84. PubMed ID: 20591421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
